← back to search
Claire Estadieu
Novartis (Switzerland) · CH
Area of research
Oncology · Cell Biology
Research interest
Research interests include Insertional mutagenesis, Mdm2, Biology, Mutagenesis, and Transposable element.
h-index
—
citations
62
works
1
NIH funding
—
primary concept
—
email
✉ Find email ↗
Recent publications
Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf <sup>−/−</sup> mouse model
Proceedings of the National Academy of Sciences
2017
cited by
62
position: middle
doi
Grants
No grants ingested yet.
Frequent collaborators
Sébastien Jeay
· Novartis (Switzerland)
1
papers (2017–2017)
Emeline Mandon
· Novartis (Switzerland)
1
papers (2017–2017)
Éric Durand
· University of California, Berkeley
1
papers (2017–2017)
William R. Sellers
· Broad Institute
1
papers (2017–2017)
Armelle Grevot
· Novartis (Switzerland)
1
papers (2017–2017)
Marion Wiesmann
· Novartis (Switzerland)
1
papers (2017–2017)
Vincent Romanet
· Novartis (Switzerland)
1
papers (2017–2017)
Louise Barys
· Novartis (Switzerland)
1
papers (2017–2017)
Masato Murakami
· Novartis (Switzerland)
1
papers (2017–2017)
Esther Sutter
· Novartis (Switzerland)
1
papers (2017–2017)
Roland Rad
· Molecular Oncology (United States)
1
papers (2017–2017)
Emilie A. Chapeau
· Novartis (Switzerland)
1
papers (2017–2017)
Ralph Tiedt
· Yale Cancer Center
1
papers (2017–2017)
Antoine de Weck
· Centre for Human Genetics
1
papers (2017–2017)
Joseph Lehár
· Fondation pour la Recherche Stratégique
1
papers (2017–2017)
Michael Rugaard Jensen
· Novartis (Switzerland)
1
papers (2017–2017)
Francesco Hofmann
· Novartis (Switzerland)
1
papers (2017–2017)
Audrey Kauffmann
· Novartis (Switzerland)
1
papers (2017–2017)
Agnieszka Gembarska
· Novartis (Switzerland)
1
papers (2017–2017)
Stéphane Ferretti
· Novartis (Switzerland)
1
papers (2017–2017)